SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02005 SSY GROUP

Not Yet Opened 09-02 16:08:07

2.730

+0.000

0.00%

High2.745	Low2.690	Vol4.73M
Open2.720	D1 Closing2.730	Amplitude2.01%
Mkt Cap7.89B	Tradable Cap7.89B	Total Shares2.89B
T/O12.86M	T/O Rate0.16%	Tradable Shares2.89B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"SSY GROUP","latestPrice":2.73,"timestamp":1788336487003,"preClose":2.73,"halted":0,"volume":4732000,"delay":0,"changeRate":0,"floatShares":2891000000,"shares":2891000000,"eps":0.1605,"marketStatus":"Not Yet Opened","change":0,"latestTime":"09-02 16:08:07","open":2.72,"high":2.745,"low":2.69,"amount":12858570,"amplitude":0.020147,"askPrice":2.73,"askSize":76000,"bidPrice":2.705,"bidSize":28000,"shortable":3,"etf":0,"ttmEps":0.174609,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":2.73,"dividendRate":0.029304,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.647188,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005","defaultTab":"news","newsList":[{"id":"2664138418","title":"SSY Group's Angina Pectoris Drug Passes Chinese Regulator's Consistency Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138418","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:14","pubTimestamp":1788344073,"startTime":"0","endTime":"0","summary":"SSY Group's  Diltiazem Hydrochloride Tablets'  passing of the quality and efficacy consistency evaluation was approved by China's National Medical Products Administration.The drug is mainly used to treat angina pectoris and mild to moderate essential hypertension, according to a Wednesday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120807026","title":"SSY Group Trustee Acquires 1.2 Million Shares Under Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1120807026","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120807026?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:02","pubTimestamp":1788339730,"startTime":"0","endTime":"0","summary":"SSY Group Ltd (HKG: 02005) has announced that on 2 September 2026, the plan trustee purchased a total of 1.2 million shares of the company on the open market.The acquisition was funded from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897460","title":"SSY Group Says China NMPA Clears Generic Consistency Review for Diltiazem Tablets 30 Mg","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897460","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897460?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:01","pubTimestamp":1788339695,"startTime":"0","endTime":"0","summary":"SSY Group says China NMPA clears generic consistency review for diltiazem tablets 30 mgChina’s NMPA cleared SSY Group’s diltiazem hydrochloride tablets (30 mg) under its generic drug consistency evalu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9Y73JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664974658","title":"SSY Group - China Approves Consistency Evaluation for SSY Group's Diltiazem Hydrochloride Tablets (30Mg)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664974658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664974658?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:01","pubTimestamp":1788339679,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U00V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02005","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897912","title":"SSY Group Buys 1,200,000 Shares at Hk$2.72 Each for Restricted Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897912","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897912?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:56","pubTimestamp":1788339418,"startTime":"0","endTime":"0","summary":"SSY Group buys 1,200,000 shares at HK$2.72 each for restricted share award schemeSSY Group’s restricted share award scheme trustee bought 1,200,000 shares on the open market on Sept. 2, 2026.Average p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLZs4z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","BK1191","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585353","title":"SSY Group Buys 1 Million Shares From Open Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585353","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664585353?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:44","pubTimestamp":1788259458,"startTime":"0","endTime":"0","summary":"SSY Group (HKG:2005) said the trustee of its share scheme bought 1 million shares from the open market on Sept. 1, according to a same-day Hong Kong bourse filing.The shares were purchased for approximately HK$2.73 million, excluding fees, using the company's internal resources.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02005","LU2460026573.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133019002","title":"SSY Group Reports Stable Share Capital and Confirms Adequate Public Float in August 2026 Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1133019002","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133019002?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255306,"startTime":"0","endTime":"0","summary":"SSY Group Limited’s Monthly Return for the period ended 31 August 2026 shows no changes in either authorised or issued share capital. Authorised shares remained at 10 billion ordinary shares with a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127687616","title":"SSY Group Trustee Acquires 900,000 Shares Under Restricted Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1127687616","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127687616?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:58","pubTimestamp":1788166699,"startTime":"0","endTime":"0","summary":"On August 31, 2026, SSY Group (02005) announced that the plan trustee had purchased a total of 900,000 shares of the company on the open market.These shares were acquired in accordance with the terms...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098596","title":"Hong Kong's Touyun Biotech Profit Surges on Fair Value Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098596","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098596?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:19","pubTimestamp":1787919573,"startTime":"0","endTime":"0","summary":"Hong Kong's Touyun Biotech profit surges on fair value gainsOverviewHong Kong biotech firm's interim revenue declined slightly yr/yr for six months ended June 2026Profit for the period surged, driven ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU1820825898.SGD","LU2460026573.USD","BK1191","00690","BK1157","BK0077","BK1576","LU1146622755.USD","01332","BK1583","02005","BK0174","BK0028","01521","300347","BK0216","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108068616","title":"Hong Kong Market Movers: Mixue's Revenue Reaches RMB 15.2 Billion in First Half, Global Store Network Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1108068616","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108068616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:12","pubTimestamp":1787879553,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) has received approval from China's National Medical Products Administration for Elenestinib (futibatinib) to treat patients with FGFR2 fusion/rearrangement intrahepatic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","BK1233","KCAI","BK1616","BK1588","02273","HK0000500386.USD","HK0000252160.HKD","VXUS","02097","09606","BK1191","BK1161","BK4585","02005","BK1587","BK1219","HK0000252152.HKD","LU2543165471.USD","BK4588","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707748","title":"SSY Group (SEHK:2005) Stock Premium Faces Pressure From Thinner Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707748","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707748?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:23","pubTimestamp":1787833395,"startTime":"0","endTime":"0","summary":"SSY Group went into this earnings print with the stock already up double digits over the past month, trading at a P/E above both peer and industry averages. The headline today is simple: the business delivered a heavier profit squeeze just as investors had been paying a premium for the stock.\nNet margin on a trailing basis is now 11.6%, down from 14.4% a year earlier, even as revenue sits at a 13.7% per year level. SSY Group is still framed around strong growth forecasts, but this set of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/ssy-group-sehk2005-stock-premium-faces-pressure-from-thinner","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/ssy-group-sehk2005-stock-premium-faces-pressure-from-thinner","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","FEBU","02005","RGLO","GXDW","VOTE","VGFPF","PMDE","DECU","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105708468","title":"SSY GROUP Secures Drug Approval for Gadobutrol Injection from China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1105708468","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105708468?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:58","pubTimestamp":1787828311,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) has announced that it has obtained the drug production registration certificate from China's National Medical Products Administration (NMPA) for its Gadobutrol Injection (7.5ml:...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2460026573.USD","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706125","title":"SSY Group - Obtains Nmpa Approval for Gadobutrol Injection Production and Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706125?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:46","pubTimestamp":1787827590,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O13D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2460026573.USD","BK1191","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662714827","title":"Singapore's Alliance Healthcare FY Revenue Rises 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662714827","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662714827?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:58","pubTimestamp":1787749115,"startTime":"0","endTime":"0","summary":"Singapore's Alliance Healthcare FY revenue rises 13%OverviewSingapore healthcare services provider's FY2026 revenue grew 13% yr/yrNet income attributable to owners for FY2026 rose 137% yr/yrPretax pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6511","A50.SI","BK6100","LU2460026573.USD","BK6092","02005","BK1191","MIJ.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662921297","title":"SSY Group Declares Interim Dividend of HKD 0.055 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662921297","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662921297?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:57","pubTimestamp":1787738233,"startTime":"0","endTime":"0","summary":"SSY Group declares interim dividend of HKD 0.055 per shareSSY Group declared an interim dividend of HKD 0.055 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Sept. 10, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7dWDjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","BK1191","LU2460026573.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129887868","title":"SSY Group Shares Surge Over 5% Intraday Following 13% Rise in First-Half Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1129887868","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129887868?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:10","pubTimestamp":1787724632,"startTime":"0","endTime":"0","summary":"SSY GROUP (02005) saw its share price climb more than 5% during the afternoon trading session, before settling to a gain of 3.78% at HK$2.61 per share, with turnover reaching HK$24.29 million.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","02005","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172226601","title":"SSY Group Schedules Interim Dividend Payment for September","url":"https://stock-news.laohu8.com/highlight/detail?id=1172226601","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172226601?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:30","pubTimestamp":1787718615,"startTime":"0","endTime":"0","summary":"SSY Group (02005) has officially announced the scheduled distribution of its interim dividend for the first half of the fiscal year, with the payment date set for September 24, 2026. According to the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2460026573.USD","BK1191","VIG","EWH","BK4588","02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276478","title":"Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276478?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:16","pubTimestamp":1787717785,"startTime":"0","endTime":"0","summary":"Hong Kong's SSY Group H1 profit rises on infusion solutions growthOverviewHong Kong pharmaceutical maker's H1 revenue rose 9.9% yr/yr to HK$2,361 mlnNet profit attributable to shareholders rose 13% to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0463099449.HKD","LU2097828557.USD","LU2097828805.USD","LU2097828714.EUR","LU0455707207.USD","BK1161","LU2242644610.SGD","LU2488822045.USD","02005","HK0000165453.HKD","LU0326950275.SGD","BK1191","LU2328871848.SGD","BK1589","LU1188198961.HKD","LU2460026573.USD","BK1583","LU0244354667.USD","KURE","LU1969619763.USD","LU0502904849.HKD","01801","LU2097828474.EUR","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138721321","title":"SSY Group posts HK$2.36 billion H1-2026 revenue, net profit up 13%; interim dividend raised 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138721321","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138721321?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717249,"startTime":"0","endTime":"0","summary":"SSY Group (Hong Kong: 02005) reported unaudited results for the six months to 30 June 2026, highlighting steady top-line growth, improved profitability and a higher interim dividend. Financial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SSY Group posts HK$2.36 billion H1-2026 revenue, net profit up 13%; interim dividend raised 10%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125908949","title":"SSY Group Declares HKD 0.055 Interim Dividend for First-Half 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1125908949","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125908949?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717233,"startTime":"0","endTime":"0","summary":"SSY Group Limited announced on 26 August 2026 that its Board has declared an ordinary interim dividend of HKD 0.055 per share for the six months ended 30 June 2026, within the financial year ending...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":0.0321},{"period":"1month","weight":0.1143},{"period":"3month","weight":0.1818},{"period":"6month","weight":0.1017},{"period":"1year","weight":-0.0137},{"period":"ytd","weight":-0.0229}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.008158},{"month":2,"riseRate":0.52381,"avgChangeRate":0.020535},{"month":3,"riseRate":0.666667,"avgChangeRate":0.079315},{"month":4,"riseRate":0.47619,"avgChangeRate":0.030939},{"month":5,"riseRate":0.47619,"avgChangeRate":0.010534},{"month":6,"riseRate":0.47619,"avgChangeRate":0.060362},{"month":7,"riseRate":0.380952,"avgChangeRate":-0.020567},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.010373},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.044171},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001891},{"month":11,"riseRate":0.65,"avgChangeRate":0.086083},{"month":12,"riseRate":0.5,"avgChangeRate":-0.009107}],"exchange":"SEHK","name":"SSY GROUP","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SSY GROUP,02005,SSY GROUP股票,SSY GROUP股票老虎,SSY GROUP股票老虎国际,SSY GROUP行情,SSY GROUP股票行情,SSY GROUP股价,SSY GROUP股市,SSY GROUP股票价格,SSY GROUP股票交易,SSY GROUP股票购买,SSY GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SSY GROUP(02005),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SSY GROUP(02005) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}